Skip to main content

Table 1 Demographic data and serological and treatment status of all patients before liver transplantation

From: Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation

Patient

Gender

Age at LT

Ethnicity

Year of LT

HBeAg

anti-HBe

anti-HBc

HBV DNA at LT

NA before LT

Cause for LT

H1

M

42

caucasian

1989

NA

NA

positive

qual. positive, quant. NA

none

Cirrhosis

H2

M

53

caucasian

1993

negative

positive

positive

270 pg/ml

none

Cirrhosis

H3

F

41

caucasian

1996

positive

positive

negative

undetectable

none

Fulminant HBV

H4

M

45

caucasian

1996

negative

negative

positive

undetectable

Lamivudine

Cirrhosis

H5

M

59

caucasian

1996

negative

negative

positive

undetectable

Lamivudine

Cirrhosis + HCC

H6

M

33

caucasian

1996

positive

negative

positive

undetectable

Lamivudine

Cirrhosis + HDV

H7

M

60

caucasian

1997

positive

negative

positive

undetectable

Lamivudine

Cirrhosis + HDV

H8

M

48

caucasian

1997

negative

negative

positive

undetectable

Lamivudine

Cirrhosis

H9

M

53

Hispanic

2000

negative

negative

positive

undetectable

Lamivudine

Cirrhosis + HCC

H10

M

48

caucasian

2000

negative

negative

positive

undetectable

Lamivudine

Cirrhosis

H11

F

43

caucasian

2000

positive

negative

negative

undetectable

none

Fulminant HBV

H12

M

63

caucasian

2001

negative

negative

positive

undetectable

Lamivudine

Cirrhosis + HCC

H13

F

54

caucasian

2001

negative

negative

positive

undetectable

Lamivudine

Cirrhosis

H14

M

60

caucasian

2002

negative

negative

positive

undetectable

Lamivudine

Cirrhosis + HCC

H15

M

58

caucasian

2002

negative

negative

positive

undetectable

Lamivudine

Cirrhosis + HCC

H16

M

60

caucasian

2002

negative

negative

positive

undetectable

Lamivudine

Cirrhosis + HCC

H17

M

60

caucasian

2003

negative

negative

positive

undetectable

Lamivudine

Cirrhosis + HCC

H18

M

48

caucasian

2004

negative

negative

positive

undetectable

Lamivudine

Cirrhosis

H19

M

51

caucasian

2005

positive

positive

negative

undetectable

none

Fulminant HBV

H20

F

30

african

2007

positive

negative

positive

undetectable

Adefovir+Lamivudine

Cirrhosis

H21

M

49

african

2007

positive

negative

positive

undetectable

Adefovir+Lamivudine

Cirrhosis + HCC